Serum Magnesium Levels in Critically Ill Patients on Admission in ICU and its Correlation with Outcome

Solanki, Jivabhai; Runwal, Kiran; Beke, Nandkumar; Bahulikar, Arun; Phalgune, Deepak.
Artículo | IMSEAR | ID: sea-216179

Documentos relacionados

  1. Evaluation of Teneligliptin a DPP4 Inhibitor in Terms of Efficacy and Safety with Respect to QT/QTc Prolongation in Patients with Type II Diabetes Mellitus (T2DM).
  2. Absence of QTc prolongation in a thorough QT study with imeglimin, a first in class oral agent for type 2 diabetes mellitus.
  3. A ProspectIve, OpeN-Label, Randomized Study Comparing EffIcacy and Safety of Teneligliptin VErsus Sitagliptin in Indian Patients with Inadequately Controlled Type 2 Diabetes Mellitus: INSITES Study.
  4. Oral magnesium supplementation does not affect insulin sensitivity in people with insulin-treated type 2 diabetes and a low serum magnesium: a randomised controlled trial.
  5. The relationship between premature ventricular complexes and index of cardiac-electrophysiological balance.